Persica Pharmaceutical’s PP353 Phase 1b Data Selected for Oral Presentation at the American Society of Interventional Pain Physicians (ASIPP) 2026 Annual Meeting

AI Briefing

• – Persica Pharmaceutical's PP353 Phase 1b data to be presented at ASIPP 2026 Annual Meeting
• – Positive data from PP353 Phase 1b Modic Trial published in The Lancet's eClinicalMedicine
• – PP353 Phase 1b Modic Trial results to be showcased at ASIPP 2026 event